Staphylococcus aureus pneumonia in children in the era of community-acquired methicillin-resistance at Texas Children's Hospital

Pediatric Infectious Disease Journal

Volumn 30, Issue 7, 2011, Pages 545-550

  Carrillo Marquez, Maria A ^a,b   Hulten, Kristina G ^a,b   Hammerman, Wendy ^a,b   Lamberth, Linda ^a,b   Mason, Edward O ^a,b   Kaplan, Sheldon L ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

empyema; lung abscess; methicillin resistance; Panton Valentine leukocidin; pneumonia; Staphylococcus aureus; USA300

Indexed keywords

BETA LACTAM ANTIBIOTIC; CLINDAMYCIN; COTRIMOXAZOLE; LINEZOLID; PANTON VALENTINE LEUKOCIDIN; VANCOMYCIN;

ADOLESCENT; ADULT; ARTICLE; BACTERIUM ISOLATE; CHILD; CLINICAL FEATURE; COMMUNITY ACQUIRED PNEUMONIA; EMPYEMA; FEMALE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; HUMAN TISSUE; INFANT; INTENSIVE CARE; LOBECTOMY; LUNG ABSCESS; LUNG BIOPSY; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESPIRATORY FAILURE; STAPHYLOCOCCAL PNEUMONIA; THORACOCENTESIS; THORACOSCOPY; TREATMENT OUTCOME; TREATMENT RESPONSE; UNITED STATES; VIDEORECORDING; VIRUS INFECTION;

EID: 79959705258     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0b013e31821618be     Document Type: Article

References (32)

1. Len KA, Bergert L, Patel S, et al. Community-acquired Staphylococcus aureus pneumonia among hospitalized children in Hawaii. Pediatr Pulmonol. 2010;45:898-905.
2. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics. 2004; 113:1735-1740. (Pubitemid 38697984)
3. Grijalva CG, Nuorti JP, Zhu Y, et al. Increasing incidence of empyema complicating childhood community-acquired pneumonia in the United States. Clin Infect Dis. 2010;50:805-813.
4. Li ST, Tancredi DJ. Empyema hospitalizations increased in US children despite pneumococcal conjugate vaccine. Pediatrics. 2010;125:26-33.
5. Gonzalez BE, Martinez-Aguilar G, Hulten KG, et al. Severe staphylococcal sepsis in adolescents in the era of community-acquired methicillin-resistant Staphylococcus aureus. Pediatrics. 2005;115:642-648. (Pubitemid 43378904)
6. Gonzalez BE, Hulten KG, Dishop MK, et al. Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection. Clin Infect Dis. 2005;41:583-590. (Pubitemid 41170343)
7. Hulten KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health care-associated Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006;25:349-353.
8. Gillet Y, Issartel B, Vanhems P, et al. Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients. Lancet. 2002;359:753-759. (Pubitemid 34215075)
9. Finelli L, Fiore A, Dhara R, et al. Influenza-associated pediatric mortality in the United States: increase of Staphylococcus aureus coinfection. Pediatrics. 2008;122:805-811.
10. Reed C, Kallen AJ, Patton M, et al. Infection with community-onset Staphylococcus aureus and influenza virus in hospitalized children. Pediatr Infect Dis J. 2009;28:572-576.
11. Kaplan SL, Hulten KG, Gonzalez BE, et al. Three-year surveillance of community-acquired Staphylococcus aureus infections in children. Clin Infect Dis. 2005;40:1785-1791. (Pubitemid 40799948)
12. Kaplan SL, Hulten KG, Hammerman WA, et al. Six-year surveillance of community-acquired Staphylococcus aureus infections in children. In: the 45th Annual Meeting of the Infectious Diseases Society of America; October 4-7, 2007; San Diego, CA.
13. McCaskill ML, Mason EO Jr, Kaplan SL, et al. Increase of the USA300 clone among community-acquired methicillin-susceptible Staphylococcus aureus causing invasive infections. Pediatr Infect Dis J. 2007;26:1122-1127. (Pubitemid 350190944)
14. Hulten KG, Kaplan SL, Lamberth LB, et al. Hospital-acquired Staphylococcus aureus infections at Texas Children's Hospital, 2001-2007. Infect Control Hosp Epidemiol. 2010;31:183-190.
15. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: 19th informational supplement M100-S19. Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
16. Hageman JC, Uyeki TM, Francis JS, et al. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis. 2006;12:894-899. (Pubitemid 43848409)
17. Burke RE, Halpern MS, Baron EJ, et al. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome. Infect Control Hosp Epidemiol. 2009;30:636-644.
18. Diep BA, Chan L, Tattevin P, et al. Polymorphonuclear leukocytes mediate Staphylococcus aureus Panton-Valentine leukocidin-induced lung inflammation and injury. Proc Natl Acad Sci USA. 2010;107:5587-5592.
19. Carrillo-Marquez MA, Hulten KG, Hammerman W, et al. USA300 is the predominant genotype causing Staphylococcus aureus septic arthritis in children. Pediatr Infect Dis J. 2009;28:1076-1080.
20. Orscheln RC, Hunstad DA, Fritz SA, et al. Contribution of genetically restricted, methicillin-susceptible strains to the ongoing epidemic of community-acquired Staphylococcus aureus infections. Clin Infect Dis. 2009; 49:536-542.
21. Bocchini CE, Hulten KG, Mason EO Jr, et al. Panton-Valentine leukocidin genes are associated with enhanced inflammatory response and local disease in acute hematogenous Staphylococcus aureus osteomyelitis in children. Pediatrics. 2006;117:433-440. (Pubitemid 46071606)
22. Labandeira-Rey M, Couzon F, Boisset S, et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science. 2007; 315:1130-1133. (Pubitemid 46328024)
23. Brown EL, Dumitrescu O, Thomas D, et al. The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect. 2009;15:156-164.
24. Gillet Y, Vanhems P, Lina G, et al. Factors predicting mortality in necrotizing community-acquired pneumonia caused by Staphylococcus aureus containing Panton-Valentine leukocidin. Clin Infect Dis. 2007;45:315-321. (Pubitemid 47101027)
25. Dufour P, Gillet Y, Bes M, et al. Community-acquired methicillin- resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. Clin Infect Dis. 2002;35:819-824.
26. Centers for Disease Control and Prevention. Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. Morb Mortal Wkly Rep. 2007;56:325-329.
27. Lobo LJ, Reed KD, Wunderink RG. Expanded clinical presentation of community-acquired MRSA pneumonia. Chest. 2010;38:130-136.
28. Stevens DL, Ma Y, Salmi DB, et al. Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Infect Dis. 2007;195:202-211. (Pubitemid 46080052)
29. Dumitrescu O, Badiou C, Bes M, et al. Effect of antibiotics, alone and in combination, on Panton-Valentine leukocidin production by a Staphylococcus aureus reference strain. Clin Microbiol Infect. 2008;14:384-388. (Pubitemid 351356532)
30. Martinez-Aguilar G, Hammerman WA, Mason EO Jr, et al. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003;22:593-598. (Pubitemid 36900204)
31. Jeffres MN, Isakow W, Doherty JA, et al. Predictors of mortality for methicillin-resistant Staphylococcus aureus health-care-associated pneumonia: specific evaluation of vancomycin pharmacokinetic indices. Chest. 2006;130:947-955. (Pubitemid 44583720)
32. Bradley JS, McCracken GH. Unique considerations in the evaluation of antibacterials in clinical trials for pediatric community-acquired pneumonia. Clin Infect Dis. 2008;47(suppl 3):S241-S248.